Form 483

Wedgewood Connect, LLC Form 483, 2021-12-03

FDA issued a Form 483 to Wedgewood Connect, LLC on 2021-12-03 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Wedgewood Connect, LLC · San Jose, United States · Issued December 3, 2021

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Dec 2021
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Jolanna A Norton, Lisa Shin

3 Dec 2021
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jolanna A Norton, Lisa Shin

3 Dec 2021
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Jolanna A Norton, Lisa Shin

3 Dec 2021
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Jolanna A Norton, Lisa Shin

Inspected site

WCWedgewood Connect, LLCSan Jose, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere